U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07539415) titled 'A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers' on Feb. 09.
Brief Summary: Phase 1 Safety and Relative Bioavailability Study of DWRX5003 in Healthy Adults
Study Start Date: March 30
Study Type: INTERVENTIONAL
Condition:
Obesity & Overweight
Type 2 Diabetes
Intervention:
DRUG: DWRX5003
Microneedle patch containing Semaglutide
DRUG: DWC202502
Semagluide
DRUG: DWC202503
Semaglutide
OTHER: DWRX5003P
placebo microneedle patch
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Daewoong Pharmaceutical Co. LTD.
Disclaimer: Curated by...